Miracle in Washington? Ozempic and Mounjaro Could Save Medicare and Medicaid

Chronic disease is bankrupting Medicare. A new class of metabolic drugs may finally change that.

For decades Washington has wrestled with the same problem: America’s healthcare system is slowly going broke. Every election cycle brings the same promises—cut costs, improve outcomes, save Medicare, fix Medicaid. Yet every year the numbers get worse as chronic disease spreads and treatment costs explode. Now, in one of the great ironies of modern polit…